Status:

NOT_YET_RECRUITING

Microbiome Sampling in GI Disease With a Focus on Small Intestinal Microbial Assessment

Lead Sponsor:

Stanford University

Conditions:

Healthy

IBS - Irritable Bowel Syndrome

Eligibility:

All Genders

18-100 years

Brief Summary

GI disorders are influenced by the gut microbiome. To date, sampling of the small intestine in GI disorders has been limited. The investigators plan to sample the small intestinal contents during endo...

Detailed Description

Current guidelines (AGA Clinical Practice Update, 2020) report the definition of SIBO as a clinical entity lacks precision and consistency; it is a term generally applied to a clinical disorder where ...

Eligibility Criteria

Inclusion

  • Age \>18years
  • Patients seen at Stanford University Digestive Health Center who are scheduled for an upper endoscopy as part of their Standard Of Care

Exclusion

  • Children (under age 18years) Pregnant Women and Fetuses Neonates (0 - 28 days) Impaired Decision Making Capacity

Key Trial Info

Start Date :

January 1 2024

Trial Type :

OBSERVATIONAL

Allocation :

ESTIMATED

End Date :

January 1 2028

Estimated Enrollment :

150 Patients enrolled

Trial Details

Trial ID

NCT06066866

Start Date

January 1 2024

End Date

January 1 2028

Last Update

October 6 2023

Active Locations (0)

Enter a location and click search to find clinical trials sorted by distance.

Page 1 of 0 (0 locations)

No Results Found

We couldn’t find results for the location/zipcode entered or within the selected range. Please check your input or adjust your search.